TFS HealthScience Elevates Miriam Martin to Key Leadership Role

LUND, Sweden – March 25, 2025 – TFS HealthScience has named Miriam Martin as its new Vice President of Business Development, Clinical Development Services (CDS), marking a significant milestone in her 15-year journey with the company. A dedicated leader with deep industry expertise, Miriam has played a pivotal role in shaping TFS’s commercial success and global expansion. From navigating key acquisitions to enhancing the company’s Functional Service Provider (FSP) model, she has been instrumental in building flexible, high-quality strategic resourcing solutions that align with the evolving needs of partners. Now joining the TFS Executive Committee, she will spearhead efforts to strengthen client engagement, accelerate business growth, and drive clinical development innovation.

Miriam’s appointment comes amid rapid advancements in TFS’s core therapeutic areas, including oncology, ophthalmology, dermatology, and neuroscience. With new clinical programs targeting diabetic macular edema, pancreatic cancer, multiple sclerosis, and complex wound healing, TFS continues to expand its scientific impact. Reflecting on her new role, Miriam expressed gratitude for the trust and investment TFS has placed in her and emphasized her commitment to fostering strong partnerships and advancing patient-centered solutions. With her leadership, the company is poised for continued momentum, reinforcing its reputation as a global leader in strategic clinical research.